Hazlett, Burt & Watson’s Adient ADNT Stock Holding History

Hazlett, Burt & Watson’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1	Closed	–	–	612
2022 Q4	$0	Buy	+1	New	+$35	﹤0.01%	611

Other funds holding ADNT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

LAM

Lyrical Asset Management New York $6.56B AUM 20.06% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Hazlett, Burt & Watson's ADNT Position: Q1 2023 in Review

Hazlett, Burt & Watson sold out of Adient (ADNT) in Q1 2023, closing a stake of 1 share.

Hazlett, Burt & Watson first reported a position in ADNT in Q4 2022 and held it in 1 quarter. The position peaked at $0 in Q4 2022. 275 funds tracked by Wall St. Rank hold ADNT as of Q1 2023.

Hazlett, Burt & Watson reported no remaining Adient position as of Q1 2023 after selling out during the quarter.
Hazlett, Burt & Watson sold 1 Adient share in Q1 2023.
Hazlett, Burt & Watson first reported a position in Adient in Q4 2022 and held it in 1 quarter.
Hazlett, Burt & Watson's Adient position peaked at $0 in Q4 2022.
275 funds tracked by Wall St. Rank held Adient as of Q1 2023.

Based on Hazlett, Burt & Watson's 13F filing for Q1 2023, filed 27 Apr 2023.